Connect with us

News

Cannabis Science and Technology® and Cannabis Patient Care™ Partner with Havas ECS to Offer Endocannabinoid Educational Courses

gbafNews28

Cannabis Science and Technology, Cannabis Patient Care„¢and Havas ECS are excited to announce a new partnership to bring a comprehensive training curriculum to all levels of students: health care professionals, patients, parents, caregivers and budtenders.

Education is key to our mission and core values, said Mike Hennessy Jr., president and CEO of MJH Life Sciences„¢, the parent company of Cannabis Science and Technology and Cannabis Patient Care„¢. We are thrilled to offer our professional audience the opportunity to become more qualified in understanding the endocannabinoid system and its therapeutic context from an innovative well- credentialed education partner.

The curriculum features three course offerings, allowing one to learn the basics of the endocannabinoid system or earn continuing medical education (CME) credits in either a three-CME course or a 12-CME course.

Introduction to Endocannabinoid Medicine is a foundational course designed to introduce health care professionals to the endocannabinoid system (ECS) and its therapeutic potential. Successful completion of this online learning system confers a total of three AMA PRA Category 1 Credits„¢ and an Introduction to Endocannabinoid Medicine certificate from Cannabis Patient Care„¢.

Certification in Endocannabinoid Medicine is a comprehensive course for medical professionals interested in gaining accredited certification in endocannabinoid medicine. Successful completion of all four levels modules confers a total of 12 AMA PRA Category 1 Credits„¢ and a Certificate in Endocannabinoid Medicine from Cannabis Patient Care„¢.

Certification in Endocannabinoid Science is an interactive learning system designed to introduce any learner to the ECS and its potential therapeutic impact. Those successfully completing this module receive an Endocannabinoid Science Certificate from Cannabis Patient Care„¢.

Together, with Cannabis Science and Technology and Cannabis Patient Care„¢, we are able to offer a comprehensive educational resource that includes exceptional medical cannabis content, thought-provoking condition-specific webcasts, and exam-based endocannabinoid system certification for medical professionals, patients, caregivers, and industry professionals, said Rob Dhoble, managing director of Havas ECS.

To learn more about the different courses and enroll, please visit www.cannabissciencetech.com/courses.

About Cannabis Science and Technology and Cannabis Patient Care„¢

Cannabis Science and Technology is a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction and cultivation. The magazine is accompanied by an online component that provides relevant information and tutorials for all members of the cannabis industry.

Cannabis Patient Care„¢magazine is an educational resource for patients, doctors, nurses, pharmacists and caregivers on the latest research, benefits and treatment options cannabis provides for a variety of illnesses. Each issue of the publication will focus on a specific disease or ailment that cannabis has been shown to be an effective remedy for. The brand will cover the current research, patient testimonials, medical perspectives and advocacy work. Our mission is to educate the medical community on the viable treatment options patients are experiencing with cannabis and the ongoing research into cannabis and cannabinoids worldwide. Cannabis Science and Technology and Cannabis Patient Care„¢are brands of MJH Life Sciences„¢, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

About Havas ECS

Havas ECS (Endocannabinoid Science) is an education and communications services company committed to health professional and consumer understanding of the endocannabinoid system, to better inform self-care, clinical decision making, and evidence-based reimbursement of medical cannabis and cannabinoid therapeutics. Havas ECS offers educational programs that increase participant understanding, and communications solutions that engage health and medical stakeholders on behalf of manufacturers, employers, insurers, governments, and medical groups. For more information, please visit www.havasECS.com. Havas ECS is a division of Havas Health & You. Havas Health & You unites Havas Life, Health4Brands (H4B), Havas Lynx, Havas Life PR and Havas Health Plus, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group. Its customer-centric approach has the talent, tenacity and technology that health-and-wellness companies, brands and people need to thrive in today’s world. For more information, go to www.HavasHealthandYou.com.

Cannabis Science and Technology® Media Contact

Alexandra Ventura, 609-716-7777

[email protected]

News

iRhythm Technologies, Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against iRhythm Technologies, Inc.

gbafNews28

RADNOR, Pa., Feb. 27, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) investors that a securities fraud class action lawsuit has been filed against iRhythm on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the “Class Period”).

Investor Deadline Alert:  Investors who purchased or acquired iRhythm common stock during the Class Period may, no later than April 2, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP:  James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at [email protected]; or click https://www.ktmc.com/irhythm-technologies-inc-securities-class-action?utm_source=PR&utm_medium=link&utm_campaign=irhythm

According to the complaint, iRhythm is a digital healthcare company that offers a portfolio of ambulatory cardiac monitoring services on its platform called the Zio service.  iRhythm receives revenue for its Zio service primarily from third-party payors, which includes commercial payors and government agencies, such as the U.S. Centers for Medicare and Medicaid Services (“CMS”). On August 3, 2020, the CMS issued its Calendar Year 2021 Medicare Physician Fee Schedule Proposed Rule, which would update payment policies, payment rates, and other provisions for services to be furnished under the Medicare Physician Fee Schedule on or after January 1, 2021.

Kevin M. King (“King”), then President and CEO of iRhythm, discussed at length how iRhythm “worked hand-in-hand with the various governing bodies . . . in drafting and constructing” the language used in the CMS's proposed rule, and that iRhythm was “well aware and well informed” of the proposed CMS rules. King praised the impact the proposed rule would have on iRhythm's business and revenues, stating that “[i]f we were to apply the new codes and proposed rates, our 2019 revenues would increase slightly,” and that “our total business will be up slightly overall.”

However, the truth began to be revealed on December 1, 2020, when the CMS issued its final rule, which finalized the codes as anticipated, but did not finalize national pricing for certain products and services offered by iRhythm. On December 2, 2020, iRhythm's common stock opened at $183.00 per share, down from the December 1, 2020 close of $240.64.

Then on January 29, 2021, Medicare Administrative Contractor, Novitas Solutions, published actual reimbursement rates under the CMS's 2021 Medicare Physician Fee Schedule. A Baird analyst commented that these rates were “way lower than” the former codes, citing one example where iRhythm was previously reimbursed around $311, but was now receiving just $42.68. Following this news, the price of iRhythm's common stock closed at $168.42 on January 29, 2021, down approximately 33% from its January 28, 2021 close of $251.00.

iRhythm investors may, no later than April 2, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP, prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
(610) 667-7706
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/irhythm-technologies-inc-reminder-kessler-topaz-meltzer–check-llp-reminds-investors-of-securities-fraud-class-action-lawsuit-filed-against-irhythm-technologies-inc-301236821.html

SOURCE Kessler Topaz Meltzer & Check, LLP

Continue Reading

News

Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of QuantumScape Corporation of Deadline in Securities Fraud Class Action Lawsuit

gbafNews28

RADNOR, Pa., Feb. 27, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against QuantumScape Corporation (NYSE: QS; QS.WS) (“QuantumScape”), f/k/a Kensington Capital Acquisition Corp. (“Kensington“) on behalf of those who purchased or acquired QuantumScape securities between November 27, 2020 and December 31, 2020, inclusive (the “Class Period”).

Deadline Reminder:  Investors who purchased or acquired QuantumScape securities during the Class Period may, no later than March 8, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at [email protected]; or click https://www.ktmc.com/quantumscape-corporation-securities-class-action?utm_source=PR&utm_medium=link&utm_campaign=qunatumscape

According to the complaint, QuantumScape develops and commercializes solid-state lithium-metal batteries for electric vehicles (“EVs”). In 2012, QuantumScape began working with Volkswagen Group of America, Inc. (“Volkswagen”) and Volkswagen Group of America Investments, LLC (“VGA”) to develop an EV battery. In 2018, Volkswagen, VGA and QuantumScape announced the establishment of a joint production project to prepare solid-state batteries for mass production. On September 3, 2020, QuantumScape announced a merger with Kensington. Upon completion of the transaction, QuantumScape would receive $1 billion in financing, including funding from VGA and the Qatar Investment Authority. That transaction was completed on November 27, 2020, and QuantumScape Class A common stock and warrants began trading on the NYSE.

The complaint alleges that on January 4, 2021, prior to the open of trading, Seeking Alpha published a research report entitled “QuantumScape's Solid State Batteries Have Significant Technical Hurdles To Overcome.” The introduction of the Seeking Alpha report emphasized that “QuantumScape's science is very good. . .[b]ut their batteries are small and unproven – not yet as big as an iWatch battery, and never tested outside a lab,” adding that “[t]here are significant risks associated with solid state batteries that have not been overcome,” and emphasizing that “[t]hey will likely never achieve the performance they claim.” Following this news, the market prices of QuantumScape publicly traded securities fell precipitously, with the price of QuantumScape's Class A common stock declining more than 63% from its Class Period high of more than $131 per share on December 22, 2020 to close down at $49.96 per share on January 4, 2021, including a one-day decline of more than $34 per share, or 41%, on January 4, 2021.

QuantumScape investors may, no later than March 8, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.

CONTACT:
Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
(610) 667-7706
[email protected] 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/kessler-topaz-meltzer–check-llp-reminds-shareholders-of-quantumscape-corporation-of-deadline-in-securities-fraud-class-action-lawsuit-301236820.html

SOURCE Kessler Topaz Meltzer & Check, LLP

Continue Reading

News

Advantage Data Honored at the Fund Intelligence Operations and Services Awards and HFM US Quant Awards 2021

gbafNews28

BOSTON, Feb. 27, 2021 /PRNewswire-PRWeb/ — Advantage Data Inc., a leading fixed-income pricing and analytics provider, today announced that it has been named the Best Cloud-Based Front Office Solution at the Fund Intelligence Operations and Services Awards 2021 as well as Best Alternative Data Provider at the HFM US Quant Awards 2021.

“Advantage Data continues to prove that it is a comparable and cost-effective alternative to Bloomberg. What used to take investors, lenders, arrangers, analysts, originators, and investor relations professionals days to complete, can now be done in a matter of seconds with Advantage Data,” said René L. Robert, President of Advantage Data. “We strive to set the industry standard in product quality, coverage, timeliness and ease of use. These awards recognize our team's commitment to providing the best market data and analytical workflow tools to credit industry professionals.”

Advantage Data has a history of excellence in the financial services industry spanning over two decades. With 15 products and services, Advantage Data aggregates data from over 2,500 sources and provides an intuitive workstation and workflow tools to users at investment banks, advisory firms, hedge funds, mutual funds, rating agencies, Business Development Companies (BDC), and other firms throughout the world.

The annual awards, organized by Pageant Media, were announced on the 24th and 25th of February, respectively.

The Fund Intelligence Operations and Services Awards 2021 is the industry's premier awards ceremony, celebrating the best in class across a broad spectrum of credit fund activity for service providers. The awards recognize and reward excellence and outstanding contributions made by business, operations & technology leaders at asset management and service provider firms over the past year.

Encompassing the full breadth of CTA managed futures and quant hedge funds, the HFM US Quant Performance Awards reward and celebrate those firms outperforming their peers. In parallel, the HFM US Quant Services Awards recognize the service providers that are assisting the industry to perform at its best.

For more information about the Fund Intelligence Operations and Services Awards 2021 or the HFM US Quant Awards 2021, please visit their websites at https://hfm.global/events/hfm-us-quant-awards-2021 and https://fiopsandservicesawards.awardstage.com/.

About Advantage Data Inc.

Founded in 1997, Advantage Data has been providing credit and credit derivative pricing, descriptive, financial and analytical information to financial institutions around the world for over two decades. Advantage Data's workstation provides access to a powerful, comprehensive and global credit platform. Thousands of sell and buy-side fixed-income analysts, traders, portfolio managers and risk management professionals rely on Advantage Data every day to access unique, powerful data quickly and easily. Likewise, banks, brokers, mutual funds, hedge funds, asset managers, insurance companies and other market participants utilize the Advantage Data feeds services for end-of-day valuation, research, and compliance functions. For more information please visit https://advantagedata.com.

Media Contact

David Diggins, AdvantageData, +1 (617) 261-9700 Ext: 4565, [email protected]

Twitter, Facebook

 

SOURCE AdvantageData

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.

Call for Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Latest Posts

gbafNews28 gbafNews28
News56 mins ago

Advantage Data Honored at the Fund Intelligence Operations and Services Awards and HFM US Quant Awards 2021

BOSTON, Feb. 27, 2021 /PRNewswire-PRWeb/ — Advantage Data Inc., a leading fixed-income pricing and analytics provider, today announced that it...

gbafNews28 gbafNews28
News56 mins ago

Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of QuantumScape Corporation of Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., Feb. 27, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities...

gbafNews28 gbafNews28
News56 mins ago

iRhythm Technologies, Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against iRhythm Technologies, Inc.

RADNOR, Pa., Feb. 27, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds iRhythm Technologies,...

gbafNews28 gbafNews28
News1 hour ago

HKGSEO Provides Free Website SEO Analysis and Consulting Services

HONG KONG SAR – Media OutReach – 22 February 2021 – The COVID-19 epidemic has lasted for nearly a year....

gbafNews28 gbafNews28
News1 hour ago

Media OutReach Expands into China with Strategic Partnership with Xinhua Finance Agency

The newswire continues growing its foothold in Asia by opening its 7th office in the region   HONG KONG SAR...

gbafNews28 gbafNews28
News1 hour ago

Voluntary Announcement: IND Approval Received for A Phase III Clinical Trial of OT-101 in the United States

HONG KONG SAR – Media OutReach – 22 February 2021 – This announcement is made by Ocumension Therapeutics (the “Company“,...

gbafNews28 gbafNews28
News1 hour ago

Citi Plus® Official Launch Ceremony

HONG KONG SAR – Media OutReach – 22 February 2021 Photo 1 Mr Lawrence Lam, Consumer Business Manager of Citibank...

gbafNews28 gbafNews28
News1 hour ago

Hong Kong Productivity Council and Hong Kong Computer Society Sign Pact to Enhance the Adoption of Emerging Technologies in Hong Kong

HONG KONG SAR – Media OutReach – 22 February 2021 – The Hong Kong Productivity Council (HKPC) and the Hong...

gbafNews28 gbafNews28
News1 hour ago

Citibank Officially Launches Citi Plus®

Co-creating With Target Clients to Suit Their Banking and Investment Needs Fostering Financial Education to Level-Up Digital Natives Through Mobile...

gbafNews28 gbafNews28
News1 hour ago

Kerry Logistics Network Extends Winning Streak at the Quamnet Outstanding Enterprise Awards for Sixth Year Running

HONG KONG SAR – Media OutReach – 22 February 2021 – Kerry Logistics Network Limited (‘Kerry Logistics Network’; Stock Code...